» Articles » PMID: 9628297

Randomized Trial Examining Cerebral Haemodynamics Following Artificial or Animal Surfactant

Overview
Journal Acta Paediatr
Specialty Pediatrics
Date 1998 Jun 17
PMID 9628297
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the effects of animal and artificial surfactants on cerebral haemodynamics, 20 premature babies receiving mechanical ventilation were randomized to receive Curosurf or Exosurf surfactant. Anterior cerebral artery blood flow velocity (CABFV) was measured using Doppler ultrasound before and up to 2 h after treatment. Following animal surfactant there was a rapid reduction in CABFV (median -36%, range -43% to +8%, p < 0.01), whereas artificial surfactant resulted in a slower rise which was less marked (median +20%, range -7% to +62%, p < 0.05). There were no significant changes in blood pressure. Two hours after administration, the oxygenation index (OI) improved significantly only in babies receiving animal surfactant. In this group there was a significant association between the change in CABFV at 1 min and the change in OI at 2h (r = 0.66, p < 0.05). Animal surfactant produces rapid improvements in ventilation which are associated with marked alterations in cerebral haemodynamics.

Citing Articles

Development of CPAP Overlay Interfaces for Efficient Administration of Aerosol Surfactant Therapy to Preterm Infants.

Jubaer H, Strickler S, Farkas D, Dalton C, Momin M, Dodson K AAPS PharmSciTech. 2025; 26(1):34.

PMID: 39821052 DOI: 10.1208/s12249-024-02987-4.


Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.

Momin M, Farkas D, Hindle M, Hall F, DiBlasi R, Longest W Pharm Res. 2024; 41(8):1703-1723.

PMID: 39112775 PMC: 11362531. DOI: 10.1007/s11095-024-03740-z.


Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.

Milesi I, Tingay D, Zannin E, Bianco F, Tagliabue P, Mosca F Pediatr Res. 2016; 80(1):92-100.

PMID: 26954481 DOI: 10.1038/pr.2016.39.


Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.

Ardell S, Pfister R, Soll R Cochrane Database Syst Rev. 2015; 8:CD000144.

PMID: 26301526 PMC: 9210808. DOI: 10.1002/14651858.CD000144.pub3.


Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?.

Suresh G, Soll R Paediatr Drugs. 2002; 4(8):485-92.

PMID: 12126452 DOI: 10.2165/00128072-200204080-00001.